STAAR Surgical Co
NASDAQ:STAA
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
| US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
27.67
52.25
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
Abbvie Inc
NYSE:ABBV
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Realty Income Corp
NYSE:O
|
US |
|
|
Walt Disney Co
NYSE:DIS
|
US |
|
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
STAAR Surgical Co
Wall Street
Price Targets
STAA Price Targets Summary
STAAR Surgical Co
According to Wall Street analysts, the average 1-year price target for
STAA
is 52.06 USD
with a low forecast of 37.37 USD and a high forecast of 63 USD.
STAA Last Price Targets
STAAR Surgical Co
The latest public price target was made on Jun 11, 2024 by
Ryan Zimmerman
from
BTIG
,
who expects
STAA
stock to
rise by 46%
over the next 12 months.
You can read more about this price target by viewing
the article on StreetInsider.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
|
Ryan Zimmerman
BTIG
|
46
USD
Upside 46% |
3 months ago
Jun 11, 2024
|
BTIG Upgrades STAAR Surgical (STAA) to Buy
StreetInsider
|
Raj Denhoy
Jefferies
|
60
USD
Upside 90% |
5 months ago
Apr 9, 2024
|
STAAR Surgical (STAA) PT Raised to $60 at Jefferies, 'Strong Start to 2024'
StreetInsider
|
John Young
Canaccord Genuity
|
46
USD
Upside 46% |
5 months ago
Apr 8, 2024
|
STAAR Surgical (STAA) PT Raised to $46 at Canaccord Genuity
StreetInsider
|
|
Margaret Kaczor
William Blair
|
45.03
USD
Upside 43% |
5 months ago
Apr 4, 2024
|
Staar Surgical upgraded to Outperform after Q1 beat at William Blair
TheFly
|
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is STAA's stock price target?
Price Target
52.06
USD
According to Wall Street analysts, the average 1-year price target for
STAA
is 52.06 USD
with a low forecast of 37.37 USD and a high forecast of 63 USD.
What is STAAR Surgical Co's Revenue forecast?
Projected CAGR
13%
For the last 8 years the
compound annual growth rate for
STAAR Surgical Co's revenue is
20%.
The projected
CAGR
for the next 3 years is
13%.
What is STAAR Surgical Co's Operating Income forecast?
Projected CAGR
27%
The
compound annual growth rate
of STAAR Surgical Co's operating income for the next 3 years is
27%.
What is STAAR Surgical Co's Net Income forecast?
Projected CAGR
43%
The
compound annual growth rate
of STAAR Surgical Co's net income for the next 3 years is
43%.
You don't have any saved screeners yet
